Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Pandemic flu toolkit for nursing facilities

A complimentary planning tool is now available to help the nation's nursing homes prepare for an influenza pandemic. The new resource is courtesy of the New Jersey Hospital Association, with grant funding from Hoffman-LaRoche.

4 Jan 2011

CEL-SCI initiates Multikine Phase III trail for head and neck cancer

CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy. CEL-SCI has now completed all of the manufacturing and regulatory requirements to begin enrollment of the study.

29 Dec 2010

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it received approval from the China State Food and Drug Administration (SFDA) to commence clinical trials for its proprietary inactivated EV71 vaccine against Hand, Foot and Mouth Disease (HFMD).

28 Dec 2010

Scientific American examines efforts to increase influenza virus monitoring in pigs to prevent pandemics in humans

Scientific American examines how, in an attempt to improve early recognition of viruses that could give rise to pandemics in people, such as last year's H1N1 swine flu, scientists are looking to better understand "the viruses that infect the estimated 941 million domesticated pigs around the world." However, as the article notes, "[i]ntensive monitoring of pig viruses is unlikely to come any time soon … Most pork-producing countries do not test their pigs at all, and in some that do - such as the U.S. - the testing is done on behalf of the pork producers.

24 Dec 2010

Over 36,000 people visit interactive infection research exhibition in 2010

The travelling exhibition organised by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) and the Robert Koch Institute (RKI), "Humans and Microbes - Robert Koch's Legacy and Modern Infection Research", has already proved to be a visitor magnet during its very first year. In total, the interactive exhibition attracted more than 36,000 visitors at its three ports of call (Berlin, Bonn and Würzburg), including 400 school classes.

23 Dec 2010

Medicago completes first part of H5N1 vaccine Phase II trial

Medicago, a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that the last dose of vaccine has been administered completing the first part of the Company's Phase II human clinical trial with its H5N1 Avian Influenza vaccine.

23 Dec 2010

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has demonstrated the ability to capture immunosuppressive exosomes derived from individuals with lymphoma and colorectal cancer.

20 Dec 2010

U.N. says it will investigate source of Haitian cholera epidemic as death toll rises

The U.N. is looking into establishing an independent commission to identify the source of Haiti's cholera epidemic, Alain Le Roy, the U.N. under-secretary-general for peacekeeping operations, said on Wednesday, the Associated Press/Washington Post reports. "We are urging and we are calling for what we could call an international panel," Le Roy said at a news conference at the U.N. headquarters in New York. "We are in discussions with (the U.N. World Health Organization) to find the best experts to be in a panel to be completely independent," he added.

17 Dec 2010

First comprehensive guide to hospital emergency preparedness exercise development

With the publication of the nation's first comprehensive, federally funded guide to hospital emergency preparedness exercise development, Dr. Nathaniel Hupert at Weill Cornell Medical College and his collaborators have provided a new toolset for strengthening hospitals' ability to protect communities nationwide against public health disasters, such as creating care centers during an influenza pandemic or treating casualties in the wake of a bioterrorism attack.

17 Dec 2010

Accelr8 reports $466,362 net sales revenue for first fiscal quarter ended October 31, 2010

Accelr8 Technology Corporation announced its financial results for the first fiscal quarter ended October 31, 2010. Net sales revenues totaled $466,362; net income from operations was $49,974 with total net income of $67,250. For the previous quarter, net sales were $15,549 with a loss from operations of $(423,373) and a total net loss of $(411,981). Shareholders' equity totaled $4,985,682 at the current quarter's end, up from $4,909,778 at the end of the previous fiscal quarter.

17 Dec 2010

CEL-SCI receives Ukraine government approval for Multikine Phase III clinical trial in head and neck cancer

CEL-SCI Corporation announced today it has received governmental approval from the Health Authority, Ministry of Health of Ukraine, to begin enrollment of subjects for a Phase III clinical trial of Multikine® in Ukraine. Multikine is the Company's flagship immunotherapy developed as a first-line standard of care in treating head and neck cancer. Ukraine is one of nine countries to participate in this global Phase III trial. The Phase III trial will be run at about 48 clinical centers, of which about 6 centers will be in Ukraine.

16 Dec 2010

Study confirms Carrageenan as effective antiviral against H1N1 influenza strain

Carrageenan, is a polymer derived from red seaweed which helps to create a protective physical barrier in the nasal cavity and has proven to be an effective antiviral in the treatment of the common cold.

16 Dec 2010

Clinical trail shows 2009 H1N1 influenza vaccine safe and effective in asthma patients

Results from a government-sponsored clinical trial of inactivated 2009 H1N1 influenza vaccine in people with asthma indicate that a single dose of vaccine was safe and induced a strong immune response predictive of protection.

14 Dec 2010

CEL-SCI reports net income of $10.48M for fiscal 2010 vs. $40.9M loss for fiscal 2009

CEL-SCI Corporation reported financial results today for the fiscal year ended September 30, 2010.

13 Dec 2010

Haitian cholera pathogen closely related to 'El Tor O1' variant from South Asia

Scientists from Pacific Biosciences of California, Inc. and Harvard Medical School have successfully employed single molecule, real-time (SMRT™) DNA sequencing technology to rapidly characterize the pathogen responsible for the recent deadly cholera epidemic in Haiti. Published online Thursday in the New England Journal of Medicine, the results provide the first whole genome sequence analysis and most detailed genetic profile to date of the Haitian Vibrio cholerae outbreak strain.

10 Dec 2010

Vibrio cholerae evolves two new mechanisms to cause similar disease

New clinical strains of cholera appear to have evolved a distinctly different mechanism to cause the same disease according to research published in the current issue of the online journal mBio-.

9 Dec 2010

Researchers develop statistical model to predict severity of seasonal influenza

Researchers have developed a statistical model for projecting how many people will get sick from seasonal influenza based on analyses of flu viruses circulating that season. The research, conducted by scientists at the National Institutes of Health, appears today in the open-access publication PLoS Currents: Influenza.

9 Dec 2010

Lung transplant saves economist from near-lethal bout of swine flu

According to the critical care experts at The Johns Hopkins Hospital who treated him, Allen Bagents, 24, of Arlington, Va., is the least likely person anyone ever expects to get sick, let alone suffer a six-week, potentially fatal bout with the swine flu, better known as H1N1 influenza.

8 Dec 2010

Vaccine World Summit to be held in New Delhi 1-3 March, 2011

From the 1st to the 3rd of March 2011, vaccine leaders from developing and developed world will meet at Vaccine World Summit in New Delhi. The event will be hosted by IMAPAC, in partnership with DCVMN (Developing Countries Vaccine Manufacturers Network).

8 Dec 2010

FDLI to launch Food and Drug Policy Forum publication in 2011

In 2011, the Food and Drug Law Institute will launch a new publication — FDLI"s Food and Drug Policy Forum. "The Policy Forum is designed to provide a new electronic marketplace for the exchange of ideas among food and drug law, regulation, and policy professionals," notes Susan C. Winckler, President and CEO of FDLI.

8 Dec 2010

Pandemic News and Research

Further Reading

Pandemic flu toolkit for nursing facilities

CEL-SCI initiates Multikine Phase III trail for head and neck cancer

Sinovac's inactivated EV71 vaccine clinical trial against HFMD receives Chinese SFDA approval

Scientific American examines efforts to increase influenza virus monitoring in pigs to prevent pandemics in humans

Over 36,000 people visit interactive infection research exhibition in 2010

Medicago completes first part of H5N1 vaccine Phase II trial

Exosomes derived from lymphoma, colorectal cancer patients circulated through Aethlon's Hemopurifier

U.N. says it will investigate source of Haitian cholera epidemic as death toll rises

First comprehensive guide to hospital emergency preparedness exercise development

Accelr8 reports $466,362 net sales revenue for first fiscal quarter ended October 31, 2010

CEL-SCI receives Ukraine government approval for Multikine Phase III clinical trial in head and neck cancer

Study confirms Carrageenan as effective antiviral against H1N1 influenza strain

Clinical trail shows 2009 H1N1 influenza vaccine safe and effective in asthma patients

CEL-SCI reports net income of $10.48M for fiscal 2010 vs. $40.9M loss for fiscal 2009

Haitian cholera pathogen closely related to 'El Tor O1' variant from South Asia

Vibrio cholerae evolves two new mechanisms to cause similar disease

Researchers develop statistical model to predict severity of seasonal influenza

Lung transplant saves economist from near-lethal bout of swine flu

Vaccine World Summit to be held in New Delhi 1-3 March, 2011

FDLI to launch Food and Drug Policy Forum publication in 2011

Best practices - optimize qPCR processes for pathogen detection eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News